Alkermes (ALKS) shifts to fully integrated biopharma, leveraging Vibrance-2, Lybalvi growth, and Avadel buy to de-risk ...

Alkermes (NASDAQ:ALKS) used its presentation at the J.P. Morgan Healthcare Conference to outline its positioning entering ...

Narcolepsy can lead to excessive daytime sleepiness, as well as cataplexy, a sudden loss of muscle tone. Other symptoms can include sleep paralysis and hallucinations that occur both during sleep ...

Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type 1 (NT1), ...

An announcement from Alkermes ( (ALKS) ) is now available.

The latest announcement is out from Alkermes ( (ALKS) ).

PLYMOUTH MEETING, Pa.-- (BUSINESS WIRE)--January 12, 2026-- ...

Investing.com -- Alkermes Plc (NASDAQ:ALKS) stock rose 3.4% in premarket trade Tuesday after the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation to the company’s ...

Centessa Pharmaceuticals (NASDAQ:CNTA) is one of the best up and coming stocks to buy according to Wall Street.

ACNP abstracts are available on the conference website and the Company’s poster will be available on the Centessa website at https://investors.centessa.com/events-presentations after the poster ...

Secil Aydinoz, MD, says helping people was his motivation in choosing medicine as a career. “The more I am able to help, the ...